Belgian venture capital firm Newton BioCapital has led a €15.3m series-B funding round for Acticor Biotech, a clinical-stage biotechnology company involved in the acute phase of thrombotic diseases.
High-net-worth individuals and family offices are hunting for yield, concerned about low interest rates and market volatility
Fund expects to hit its target in the first quarter of 2020 and has already made six investments
Soprome and BTC Capital also back the takeover of the security services company
Perlego offers access to online textbooks for a subscription fee of £12 per month